ASM Oral Presentation Australian Society for Microbiology Annual Scientific Meeting 2025

Repurposing the CF drug ivacaftor as an efflux pump inhibitor to reduce resistance and virulence in Pseudomonas aeruginosa (121029)

Sida Liu 1 , Sylvia Sapula 1 , Susan Semple 2 , Judith M Morton 3 , Rietie Venter 1
  1. Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
  2. Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia
  3. Royal Adelaide Hospital, Adelaide, South Australia, Australia
Publish consent withheld